Company Information
Member Since 1 Year
Nature of Business Manufacturer Year of Establishment 2020Ask for more detail from the seller
Contact Supplier
Danyelza is used, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), to treat pediatric patients aged 1 year and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have a partial response, minor response, or stable disease to prior therapy.
Connect with us
For Buyer 
For Seller 
Help 
Shahdara, Delhi 
Send Enquiry